Korean J Pain.  2013 Jan;26(1):98-101. 10.3344/kjp.2013.26.1.98.

Clinical Experiences on the Effect of Scrambler Therapy for Patients with Postherpetic Neuralgia

• Ko YK
• Lee HY
• Lee WY

• KMID: 1779034
• DOI: http://doi.org/10.3344/kjp.2013.26.1.98

Abstract

Postherpetic neuralgia (PHN) is a debilitating complication of herpes zoster, especially in elderly and comorbid patients. Unfortunately, the currently available treatments have shown limited efficacy and some adverse events that are poorly tolerated in elderly patients. Scrambler Therapy, proposed as an alternative treatment for chronic neuropathic pain recently, is a noninvasive approach to relieve pain by changing pain perception at the brain level. Here, we report our clinical experiences on the effect of Scrambler Therapy for three patients with PHN refractory to conventional treatment.

Keyword

chronic neuropathic pain; noninvasive approach; postherpetic neuralgia; Scrambler Therapy

MeSH Terms

Aged
Brain
Herpes Zoster
Humans
Neuralgia
Neuralgia, Postherpetic
Pain Perception

Figure

• 

  Fig. 1 MC5-A Model. Calmare® consists of a multiprocessor with five channels capable of treating five painful areas in the same patient simultaneously.

• 

  Fig. 2 A patient complained of pain in the right scapular area around the T3 dermatome. We applied each of 2 surface electrodes in five channels on the skin around the painful areas, not in the painful areas.

• 

  Fig. 3 Change of visual analogue scale (VAS) after Scrambler Therapy in three patients.

Reference

1. Kim C. Pathophysiology of postherpetic neuralgia. J Korean Pain Soc. 2004; 17:S13–S16.

2. Galluzzi KE. Management strategies for herpes zoster and postherpetic neuralgia. J Am Osteopath Assoc. 2007; 107:S8–S13. PMID: 17488885.

3. Marineo G, Iorno V, Gandini C, Moschini V, Smith TJ. Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot, randomized, controlled trial. J Pain Symptom Manage. 2012; 43:87–95. PMID: 21763099.

4. Marineo G. Untreatable pain resulting from abdominal cancer: new hope from biophysics? JOP. 2003; 4:1–10. PMID: 12555009.

5. Sabato AF, Marineo G, Gatti A. Scrambler therapy. Minerva Anestesiol. 2005; 71:479–482. PMID: 16012423.

6. Ricci M, Pirotti S, Scarpi E, Burgio M, Maltoni M, Sansoni E, et al. Managing chronic pain: results from an open-label study using MC5-A Calmare® device. Support Care Cancer. 2012; 20:405–412. PMID: 21394458.

7. Marineo G, Spaziani S, Sabato AF, Marotta F. Artificial neurons in oncological pain: the potential of Scrambler Therapy to modify a biological information. Int Congr Ser. 2003; 1255:381–388.

8. Smith TJ, Coyne PJ, Parker GL, Dodson P, Ramakrishnan V. Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare®) for chemotherapy-induced peripheral neuropathy. J Pain Symptom Manage. 2010; 40:883–891. PMID: 20813492.